Tissue Acquisition and Cellular / Molecular Analysis Shared Resource (TACMASR) The goal of the Tissue Acquisition and Cellular / Molecular Analysis Shared Resource (TACMASR) is to provide University of Arizona Cancer Center (UACC) investigators with access to clinically annotated high quality human specimens through a meticulously maintained biorepository coupled with advanced human and animal tissue analysis using state-of-the art instrumentation and expert analysis and interpretation of results by well trained staff. A universal consent enables TACMASR to procure, manage, annotate, and distribute tissue, blood and urine specimens from consented patients. The UACC biorepository consists of a central collection that includes surgical specimens from multiple organ sites and several special collections developed as the result of several large grants. An oversight committee prioritizes specimen use. The TACMASR provides the following services: 1) biorepository services for high quality sample collection, storage, preparation, and processing as well as consultation, 2) histology and immunohistochemistry, 3) cellular and molecular pathology, 4) microscopy (brightfield, phase contrast, and widefield fluorescence), and 5) education about associated techniques and data analysis. The TACMASR also provides consultation and assistance concerning experimental design, sample preparation, probe selection, and referrals to resources for data analysis. The TACMASR has contributed to major national biorepository efforts, including the International Genome Consortium, by contributing specimens that were entered into the Cancer Genome Atlas and the Expression Project for Oncology.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA023074-39
Application #
9735131
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
39
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Arizona
Department
Type
DUNS #
806345617
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Knudsen, Erik S; Balaji, Uthra; Mannakee, Brian et al. (2018) Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility. Gut 67:508-520
Boese, Cody J; Nye, Jonathan; Buster, Daniel W et al. (2018) Asterless is a Polo-like kinase 4 substrate that both activates and inhibits kinase activity depending on its phosphorylation state. Mol Biol Cell 29:2874-2886
Sohail, Atif; Mushtaq, Adeela; Iftikhar, Ahmad et al. (2018) Emerging immune targets for the treatment of multiple myeloma. Immunotherapy 10:265-282
Doane, Cynthia J; Patil, Karuna; Hoffman, Emely A et al. (2018) Supernumerary Incisors in CB6F1 Mice Conditioned with Chemotherapy and Total Body Irradiation before Bone Marrow Transplantation. Comp Med 68:349-352
Bea, J W; Hsu, C-H; Blew, R M et al. (2018) Use of iDXA spine scans to evaluate total and visceral abdominal fat. Am J Hum Biol 30:
Lent, Adrienne B; O'Connor, Patrick A; Reikowsky, Ryan C et al. (2018) Quit outcomes among clients ineligible for cessation medication through the state quitline: a retrospective, observational study. BMC Public Health 18:1001
Bulkley, Joanna E; McMullen, Carmit K; Grant, Marcia et al. (2018) Ongoing ostomy self-care challenges of long-term rectal cancer survivors. Support Care Cancer 26:3933-3939
Zaim, Samir Rachid; Li, Qike; Schissler, A Grant et al. (2018) Emergence of pathway-level composite biomarkers from converging gene set signals of heterogeneous transcriptomic responses. Pac Symp Biocomput 23:484-495
Kobes, Joseph E; Georgiev, George I; Louis, Anthony V et al. (2018) A Comparison of Iron Oxide Particles and Silica Particles for Tracking Organ Recellularization. Mol Imaging 17:1536012118787322
Kelly, K R; Espitia, C M; Zhao, W et al. (2018) Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy. Leukemia 32:230-233

Showing the most recent 10 out of 1336 publications